Kcuk.org.uk

93 percent had tumor growth controlled for median of more than 8 months, researchers report WEDNESDAY, Nov. 30, 2016 (HealthDay News) — An experimental drug may show promise in treating kidney cancer, researchers say. The drug CB-839 is the first to...

Some Advanced Kidney Cancer Patients May Postpone Treatment: MedlinePlus Some Advanced Kidney Cancer Patients May Postpone Treatment In cases of slow-growing disease, toxic drugs can sometimes be avoided for many months, study finds By Robert Preidt...

Two new kidney cancer drugs ‘work’ 26 September 2015 From the section Health Two new therapies for hard to treat advanced kidney cancer could change treatment of the disease, say experts at the European Cancer Congress. Both drugs increased survival...

Results of Phase III Clinical Study of Advanced Kidney Cancer Patients after Surgery Revealed No Survival Benefit for Sunitinib, Sorafenib

An immunotherapy drug has been described as a potential “game-changer” in promising results presented at the European Cancer Congress. In a study of head and neck cancer, more patients taking nivolumab survived for longer compared with those who were...